Results 201 to 210 of about 14,050 (297)

Procedure for Changing an Impella Device While Maintaining Guide Wire Access: A Novel Technique

, 2017
Tigran Khachatryan, Howard Haw-Chang Lan, Deepika Narasimha, Ken Jutzy, Anthony Hilliard, Danish Siddiqui, Islam Abudayyeh   +6 more
openalex   +2 more sources

Response by Amin et al to Letters Regarding Article, “The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support” [PDF]

, 2020
Amit P. Amin, Sunil V. Rao, Richard G. Bach, Jeptha P. Curtis, Nihar R. Desai, Christian McNeely, Firas Al-Badarin, John A. House, Hemant Kulkarni, Frederick A. Masoudi, John A. Spertus   +10 more
openalex   +1 more source

Beating Heart Coronary Artery Bypass Grafting with Preemptive Impella^™ 5.5 Assist Device in Ischemic Cardiomyopathy. [PDF]

Biomedicines
Cabrucci F, Baudo M, Yamashita Y, Yakobitis A, Murray C, Torregrossa G.   +5 more
europepmc   +1 more source

High‑risk coronary angioplasty protected by an Impella pump combined with simultaneous iliac artery angioplasty [PDF]

, 2019
Wojciech Balak, Joanna Wı́sniewska, Michał Ziółkowski, Marcin Walukiewicz, Gabriel Bielawski, Grzegorz Grześk   +5 more
openalex   +1 more source

Role of computed tomography and chest radiography in imaging of Impella heart pump and associated complications. [PDF]

J Clin Imaging Sci
Hoang T, Baran TM, Marinescu M, Mandalapu A, Chaturvedi A.   +4 more
europepmc   +1 more source

Letter by Delmas et al Regarding Article, “Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis” [PDF]

, 2019
Clément Delmas, Marc Laine, Laurent Bonello   +2 more
openalex   +1 more source

Impella 5.5 Use in the Setting of Severe Aortic Insufficiency: A Relative Contraindication

Annals of Thoracic Surgery Short Reports
Moderate or severe aortic insufficiency is a contraindication to transvalvular Impella left ventricular assist device (Abiomed) use out of concern for worsening valvular insufficiency and recirculation. This report describes the case of a 75-year-old man
Omar M. Sharaf, BS, Christopher Bobba, MD, PhD, Matheus P. Falasa, MD, Luke Landolt, MD, Todd E. Jones, MD, Patrick Millan, MD, Eric I. Jeng, MD, MBA   +6 more
doaj  

Cardiogenic shock 2025: Understanding real world outcomes and contemporary practice to help guide improvements in care. [PDF]

Am Heart J Plus
Johnston PV.
europepmc   +1 more source

TCT-550 Comparative Clinical Outcomes with the Initial Use of Impella CP versus Impella 5.0 Devices in Patients with Severe Cardiogenic Shock

, 2017
Rikin Tank, Richard Cheng, Danny Ramzy, F. Esmailian, Jon Kobashigawa, J. Moriguchi, Francisco A. Arabía, Babak Azarbal   +7 more
openalex   +1 more source

Impella-Protected High-Risk Percutaneous Coronary Intervention in the Elderly: Balancing Feasibility and Necessity. [PDF]

J Am Heart Assoc
Bogerd M, Henriques JPS.
europepmc   +1 more source